NCT06337318 2026-03-18Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaNational Cancer Institute (NCI)Phase 3 Recruiting600 enrolled
NCT03267433 2026-03-02Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete RemissionEastern Cooperative Oncology GroupPhase 3 Active not recruiting689 enrolled